Astellas Pharma, Inc. engages in the research, development, manufacture, import, and export of pharmaceutical products. Its products focus on therapeutic fields that include transplantation, immunology, infectious diseases, urology, oncology, neuroscience, diabetic complications, and metabolic diseases. The firm's global brands include Prograf, Vesicare, Protopic, Harnal, and Funguard. The company was founded by Kenji Yamanouchi in April 1923 and is headquartered in Tokyo, Japan.
Company profile
Ticker
ALPMY, ALPMF
Exchange
Website
CEO
Kenji Yasukawa
Employees
Incorporated
Location
Fiscal year end
SEC CIK
ALPMY stock data
Latest filings (excl ownership)
F-6EF
Automatic registration for ADRs (foreign)
22 Nov 19
F-6EF
Automatic registration for ADRs (foreign)
21 Dec 17
F-6 POS
Automatic registration for ADRs (post-effective amendment, foreign)
29 Sep 17
F-6EF
Automatic registration for ADRs (foreign)
15 Oct 14
F-6 POS
Automatic registration for ADRs (post-effective amendment, foreign)
2 Apr 14
F-6 POS
Automatic registration for ADRs (post-effective amendment, foreign)
24 Mar 14
F-6 POS
Automatic registration for ADRs (post-effective amendment, foreign)
24 Mar 14
F-6 POS
Automatic registration for ADRs (post-effective amendment, foreign)
20 Mar 14
F-6 POS
Automatic registration for ADRs (post-effective amendment, foreign)
13 May 13
F-6 POS
Automatic registration for ADRs (post-effective amendment, foreign)
13 May 13
Latest ownership filings
No filings
Institutional ownership, Q2 2023
0.0% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 12 |
Opened positions | 9 |
Closed positions | 1 |
Increased positions | 0 |
Reduced positions | 1 |
13F shares | Current |
---|---|
Total value | 9.93 bn |
Total shares | 668.06 k |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Renaissance | 418.99 k | $6.23 bn |
Veredus Asset Management | 199.10 k | $2.96 bn |
Rhumbline Advisers | 34.74 k | $516.64 mm |
MAI Capital Management | 11.22 k | $166.83 mm |
Paradigm Asset Management | 2.50 k | $37.18 mm |
Cassady Schiller Wealth Management | 698.00 | $10.38 mm |
Russell Investments | 391.00 | $5.81 mm |
PNC PNC Financial Services | 172.00 | $2.56 mm |
First Horizon Advisors | 114.00 | $1.69 mm |
Motco | 91.00 | $1.35 mm |